Changing Minds
Transforming Psychedelics into Medicines
MindMed strives to deliver on the therapeutic potential of psychedelics and other novel compounds to address unmet patient needs in the fields of psychiatry, addiction, pain and neurology.
A psychedelic drug development company designing altered states of consciousness for mental health therapeutics
A biopharmaceutical company "redefining how the world approaches, prevents, and heals mental health disorders"
Root-Cause Resolution Medicine
Paul Stamets´ mushroom supplements and much more
The Multidisciplinary Association for Psychedelic Studies
A biannual print magazine and psychedelic media company
Mental health and well-being company that offers Ketamine assisted therapy to treat anxiety and depression
A Psychedelic-Specialist Clinical Research Organisation
Beckley Psytech is dedicated to helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines
UK-based biotech company pioneering a new combination therapy for treatment resistant depression
